Analysed TUHURA BIOSCIENCES INC (HURA:NASDAQ) News Sources
TuHURA Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update
01-04-2026
yahoo.com
TuHURA Biosciences Appoints Amanda Garofalo, MSHS, as Senior Vice President of Clinical Operations
07-04-2026
yahoo.com
Is TuHURA Biosciences (HURA) One of the Unstoppable Stocks That Could Double Your Money?
20-04-2026
yahoo.com
TuHURA Biosciences Announces $50 Million Credit Facility and Royalty Transaction Extending Anticipated Cash Runway into 2028
22-04-2026
yahoo.com
TuHURA Biosciences to Present at the 4th Annual H.C. Wainwright BioConnect Investor Conference
12-05-2026
yahoo.com
TuHURA Biosciences Reports First Quarter 2026 Financial Results and Provides a Corporate Update
15-05-2026
yahoo.com
TuHURA Biosciences Files Investigational New Drug Application for Evaluation of the TBS-2025 VISTA Inhibiting Antibody in Molecularly Defined Subsets of AML and Other Blood Related Cancers
15-06-2026
yahoo.com
TuHURA Biosciences to Present at Canaccord Genuity's 46th Annual Growth Conference
22-07-2026
yahoo.com
What is the current price of TUHURA BIOSCIENCES INC (HURA:NASDAQ)?
The current price of TUHURA BIOSCIENCES INC (HURA:NASDAQ) is $2.04.
TUHURA BIOSCIENCES INC (HURA:NASDAQ) absolute price change since previous trading day?
The absolute price change of TUHURA BIOSCIENCES INC (HURA:NASDAQ) since the previous trading day is $-0.11.
TUHURA BIOSCIENCES INC (HURA:NASDAQ) percentage price change since previous trading day?
The percentage price change of TUHURA BIOSCIENCES INC (HURA:NASDAQ) since the previous trading day is -5.1163%.
What is the most recent average sentiment score for TUHURA BIOSCIENCES INC (HURA:NASDAQ)?
The most recent average sentiment score for TUHURA BIOSCIENCES INC (HURA:NASDAQ) is 80 out of 100.
What is the most recent average sentiment for TUHURA BIOSCIENCES INC (HURA:NASDAQ)?
The most recent sentiment for TUHURA BIOSCIENCES INC (HURA:NASDAQ) is .
SEC-8K** Filing Available For TUHURA BIOSCIENCES INC (HURA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.